Rice Hall James & Associates’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.6M | Sell |
108,382
-1,291
| -1% | -$162K | 0.73% | 40 |
|
2025
Q1 | $12.1M | Sell |
109,673
-959
| -0.9% | -$106K | 0.71% | 42 |
|
2024
Q4 | $15.1M | Sell |
110,632
-6,785
| -6% | -$926K | 0.83% | 34 |
|
2024
Q3 | $13.5M | Sell |
117,417
-688
| -0.6% | -$79.3K | 0.73% | 42 |
|
2024
Q2 | $16.3M | Sell |
118,105
-8,316
| -7% | -$1.14M | 0.98% | 25 |
|
2024
Q1 | $17.4M | Sell |
126,421
-5,200
| -4% | -$717K | 1% | 25 |
|
2023
Q4 | $17.3M | Sell |
131,621
-592
| -0.4% | -$78K | 1% | 26 |
|
2023
Q3 | $14.9M | Sell |
132,213
-2,857
| -2% | -$321K | 0.94% | 31 |
|
2023
Q2 | $12.7M | Sell |
135,070
-2,167
| -2% | -$204K | 0.72% | 43 |
|
2023
Q1 | $13.9M | Sell |
137,237
-12,130
| -8% | -$1.23M | 0.79% | 36 |
|
2022
Q4 | $17.8M | Sell |
149,367
-3,552
| -2% | -$424K | 1.02% | 26 |
|
2022
Q3 | $16.2M | Sell |
152,919
-49,627
| -25% | -$5.27M | 0.94% | 29 |
|
2022
Q2 | $19.7M | Sell |
202,546
-4,209
| -2% | -$410K | 0.95% | 31 |
|
2022
Q1 | $19.4M | Buy |
206,755
+136,782
| +195% | +$12.8M | 0.77% | 39 |
|
2021
Q4 | $5.96M | Sell |
69,973
-8,052
| -10% | -$686K | 0.21% | 93 |
|
2021
Q3 | $7.48M | Sell |
78,025
-5,231
| -6% | -$502K | 0.28% | 77 |
|
2021
Q2 | $8.1M | Sell |
83,256
-14
| -0% | -$1.36K | 0.29% | 74 |
|
2021
Q1 | $8.1M | Sell |
83,270
-3,848
| -4% | -$374K | 0.26% | 78 |
|
2020
Q4 | $8.35M | Buy |
87,118
+12,938
| +17% | +$1.24M | 0.29% | 73 |
|
2020
Q3 | $7.13M | Buy |
74,180
+9,140
| +14% | +$879K | 0.29% | 75 |
|
2020
Q2 | $7.94M | Sell |
65,040
-993
| -2% | -$121K | 0.34% | 82 |
|
2020
Q1 | $5.72M | Sell |
66,033
-824
| -1% | -$71.3K | 0.32% | 92 |
|
2019
Q4 | $7.19M | Buy |
66,857
+5,362
| +9% | +$576K | 0.24% | 115 |
|
2019
Q3 | $5.54M | Sell |
61,495
-654
| -1% | -$58.9K | 0.2% | 116 |
|
2019
Q2 | $5.25M | Sell |
62,149
-11,575
| -16% | -$977K | 0.17% | 126 |
|
2019
Q1 | $6.5M | Buy |
73,724
+29,983
| +69% | +$2.64M | 0.21% | 121 |
|
2018
Q4 | $3.12M | Buy |
+43,741
| New | +$3.12M | 0.11% | 134 |
|